Skip to content
Global sound
The David Rubenstein Show

The David Rubenstein Show

Joaquin Duato

· 24 min

Show notes

Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duato also talked about how artificial intelligence could accelerate drug discovery and the development of new medicines. He's on this week's episode of The David Rubenstein Show: Peer to Peer Conversations. This interview was recorded June 16 at The Economic Club of Washington.
See omnystudio.com/listener for privacy…

Website: omny.fm

Live, last hour: 9,837 songs on 5,217 stations in 147 countries

Discover the world through radio

More ways to discover (9)

Heard something good? Save it, or open it straight away in Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
Radio 538 luisteren - Live!Popular right now